Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Shares Traded Last Trade
  -1.00p -3.57% 27.00p 19,284 16:29:08
Bid Price Offer Price High Price Low Price Open Price
25.00p 29.00p 28.00p 27.00p 28.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.94 -7.79 -31.90 9.2

Genedrive (GDR) Latest News

More Genedrive News
Genedrive Takeover Rumours

Genedrive (GDR) Share Charts

1 Year Genedrive Chart

1 Year Genedrive Chart

1 Month Genedrive Chart

1 Month Genedrive Chart

Intraday Genedrive Chart

Intraday Genedrive Chart

Genedrive (GDR) Discussions and Chat

Genedrive Forums and Chat

Date Time Title Posts
19/12/201810:47Still waiting....45
02/10/201808:39Genedrive (GDR) One to Watch -

Add a New Thread

Genedrive (GDR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2019-01-22 16:29:0226.105,0001,305.00O
2019-01-22 16:24:3326.006,0071,561.82O
2019-01-22 12:43:2227.001,277344.79O
2019-01-22 09:38:5926.007,0001,820.00O
View all Genedrive trades in real-time

Genedrive (GDR) Top Chat Posts

DateSubject
22/1/2019
08:20
Genedrive Daily Update: Genedrive is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 28p.
Genedrive has a 4 week average price of 18.50p and a 12 week average price of 18.50p.
The 1 year high share price is 40.50p while the 1 year low share price is currently 18.50p.
There are currently 34,000,506 shares in issue and the average daily traded volume is 60,096 shares. The market capitalisation of Genedrive is £9,180,136.62.
17/10/2017
13:37
walbrock82: Despite the rise in today’s share price, Genedrive’s results are poor. Revenue missed their £7m forecast and net losses widened to £6.4m, greater than their sales of £5.8m. The problems facing this diagnostic business is two-fold: -One R&D expenses account for 90% of group sales (normally you would expect 20%). Also, it grows larger as sales increase. -Two staff costs represent half of sales. Also, 40% of group sales is reliance on grant funding which is a volatile source of income. But, right now it is helping to mask internal sales weakness within the business. Those who participate in last year placing at 80p is down by 55%. For more Genedrive analysis and other analysis on companies’ results, click http://bit.ly/2hLViFb
Genedrive share price data is direct from the London Stock Exchange
Your Recent History
LSE
GDR
Genedrive
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190123 01:26:47